Exploring Analgesic Use Patterns Among Cancer Survivors With Chronic Chemotherapy-Induced Peripheral Neuropathy
Duloxetine, the first-line treatment for chronic CIPN pain, was used less frequently than gabapentin, a common prescription analgesic for neuropathic pain. Further research is needed to determine strategies to promote the implementation of evidence-based CIPN treatments in clinical practice.
Authors
- Michael B. Sohn (ORCID: https://orcid.org/0000-0002-4981-8351)
- Mark Allen O’Rourke (ORCID: https://orcid.org/0000-0003-1707-6186)
- Lynn R. Gauthier (ORCID: https://orcid.org/0000-0003-0138-0167)
- Robert Knoerl (ORCID: https://orcid.org/0000-0002-6996-5068)
- Karen Michelle Mustian (ORCID: https://orcid.org/0000-0001-6525-7518)
- Jennifer S. Gewandter (ORCID: https://orcid.org/0000-0001-7938-6775)
- Melyssa Foust
- Lori Francar
- Gary M Morrow
Institutions
- University of South Carolina (US)
- University of Michigan (US)
- University of Rochester Medical Center (US)
- Université Laval (CA)
Publication Details
- Journal
- Oncology nursing forum
- Published
- 2024-08-20
- DOI
- https://doi.org/10.1188/24.onf.445-450
- Citations
- 1
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- National Cancer Institute